Haig P. Bozigian Insider Trading $NBIX NEUROCRINE BIOSCIENCES INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Haig P. Bozigian.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Haig P. Bozigian. Haig P. Bozigian is Chief Development Officer in NEUROCRINE BIOSCIENCES INC ($NBIX) and Sr Vice President, Development in NEUROCRINE BIOSCIENCES INC ($NBIX).
Haig P. Bozigian in NEUROCRINE BIOSCIENCES INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Haig P. Bozigian: Chief Development Officer, Sr Vice President, Development
Holdings: 153,328 shares
Current Value: $6,685,101
Latest Transaction: Feb 09 2021
$NBIX Market Capitalization: $3.81B
$NBIX Previous Close: $43.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Haig P. Bozigian in NEUROCRINE BIOSCIENCES INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 09 2021 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | A | 0.00 | 532 | 0 | 532 | |
| Feb 09 2021 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | A | 117.63 | 3,188 | 375,004 | 3,188 | |
| Feb 09 2021 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 116.79 | 1,623 | 189,550 | 157,651 | 159.3 K to 157.7 K (-1.02 %) |
| Feb 09 2021 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 116.78 | 1,395 | 162,912 | 156,189 | 157.6 K to 156.2 K (-0.89 %) |
| Feb 09 2021 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 116.85 | 824 | 96,286 | 154,934 | 155.8 K to 154.9 K (-0.53 %) |
| Feb 09 2021 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 113.79 | 704 | 80,109 | 153,328 | 154 K to 153.3 K (-0.46 %) |
| Nov 16 2020 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 90.74 | 2,257 | 204,806 | 152,694 | 155 K to 152.7 K (-1.46 %) |
| Aug 07 2020 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 118.89 | 2,257 | 268,324 | 150,663 | 152.9 K to 150.7 K (-1.48 %) |
| May 14 2020 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 81.05 | 18,057 | 1,463,520 | 47,383 | |
| May 14 2020 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 81.49 | 15,833 | 1,290,231 | 13,340 | |
| May 14 2020 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 43.24 | 18,571 | 803,010 | 15,289 | |
| May 14 2020 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 35.99 | 9,094 | 327,293 | 0 | |
| May 14 2020 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 114.94 | 18,057 | 2,075,549 | 148,633 | 166.7 K to 148.6 K (-10.83 %) |
| May 14 2020 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 81.05 | 18,057 | 1,463,520 | 166,690 | 148.6 K to 166.7 K (+12.15 %) |
| May 14 2020 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 114.94 | 15,833 | 1,819,913 | 148,633 | 164.5 K to 148.6 K (-9.63 %) |
| May 14 2020 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 81.49 | 15,833 | 1,290,231 | 164,466 | 148.6 K to 164.5 K (+10.65 %) |
| May 14 2020 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 114.94 | 18,571 | 2,134,631 | 148,633 | 167.2 K to 148.6 K (-11.11 %) |
| May 14 2020 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 43.24 | 18,571 | 803,010 | 167,204 | 148.6 K to 167.2 K (+12.49 %) |
| May 14 2020 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 114.94 | 9,094 | 1,045,303 | 148,633 | 157.7 K to 148.6 K (-5.77 %) |
| May 14 2020 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 35.99 | 9,094 | 327,293 | 157,727 | 148.6 K to 157.7 K (+6.12 %) |
| Apr 28 2020 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 99.46 | 1,934 | 192,351 | 148,633 | 150.6 K to 148.6 K (-1.28 %) |
| Feb 11 2020 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 103.33 | 1,623 | 167,702 | 146,641 | 148.3 K to 146.6 K (-1.09 %) |
| Feb 07 2020 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | A | 0.00 | 2,430 | 0 | 2,430 | |
| Feb 07 2020 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | A | 102.90 | 15,337 | 1,578,177 | 15,337 | |
| Feb 07 2020 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 101.56 | 1,395 | 141,670 | 145,180 | 146.6 K to 145.2 K (-0.95 %) |
| Feb 07 2020 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 103.06 | 704 | 72,556 | 143,925 | 144.6 K to 143.9 K (-0.49 %) |
| Feb 07 2020 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 103.00 | 1,342 | 138,223 | 143,292 | 144.6 K to 143.3 K (-0.93 %) |
| Jul 31 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 43.24 | 25,600 | 1,106,944 | 33,860 | |
| Jul 31 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 32.99 | 18,756 | 618,760 | 0 | |
| Jul 31 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 93.52 | 25,600 | 2,394,227 | 141,976 | 167.6 K to 142 K (-15.28 %) |
| Jul 31 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 43.24 | 25,600 | 1,106,944 | 167,576 | 142 K to 167.6 K (+18.03 %) |
| Jul 31 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 91.74 | 18,756 | 1,720,630 | 141,976 | 160.7 K to 142 K (-11.67 %) |
| Jul 31 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 32.99 | 18,756 | 618,760 | 160,732 | 142 K to 160.7 K (+13.21 %) |
| Jul 17 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 32.99 | 30,680 | 1,012,133 | 18,756 | |
| Jul 17 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 87.50 | 30,680 | 2,684,506 | 141,976 | 172.7 K to 142 K (-17.77 %) |
| Jul 17 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 32.99 | 30,680 | 1,012,133 | 172,656 | 142 K to 172.7 K (+21.61 %) |
| Jul 12 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 32.99 | 100 | 3,299 | 49,436 | |
| Jul 12 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 32.99 | 7,120 | 234,889 | 49,536 | |
| Jul 12 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 87.59 | 100 | 8,759 | 141,976 | 142.1 K to 142 K (-0.07 %) |
| Jul 12 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 32.99 | 100 | 3,299 | 142,076 | 142 K to 142.1 K (+0.07 %) |
| Jul 12 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 87.63 | 7,120 | 623,958 | 141,976 | 149.1 K to 142 K (-4.78 %) |
| Jul 12 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 32.99 | 7,120 | 234,889 | 149,096 | 142 K to 149.1 K (+5.01 %) |
| Jun 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 32.99 | 2,100 | 69,279 | 56,656 | |
| Jun 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 87.82 | 2,100 | 184,417 | 141,976 | 144.1 K to 142 K (-1.46 %) |
| Jun 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 32.99 | 2,100 | 69,279 | 144,076 | 142 K to 144.1 K (+1.48 %) |
| Jun 17 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 32.99 | 1,432 | 47,242 | 58,756 | |
| Jun 17 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 19.59 | 15,836 | 310,227 | 0 | |
| Jun 17 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 83.29 | 1,432 | 119,271 | 141,976 | 143.4 K to 142 K (-1.00 %) |
| Jun 17 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 32.99 | 1,432 | 47,242 | 143,408 | 142 K to 143.4 K (+1.01 %) |
| Jun 17 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 82.56 | 15,836 | 1,307,357 | 141,976 | 157.8 K to 142 K (-10.03 %) |
| Jun 17 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 19.59 | 15,836 | 310,227 | 157,812 | 142 K to 157.8 K (+11.15 %) |
| Jun 05 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 19.59 | 3,435 | 67,292 | 15,836 | |
| Jun 05 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 85.51 | 3,435 | 293,719 | 141,976 | 145.4 K to 142 K (-2.36 %) |
| Jun 05 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 19.59 | 3,435 | 67,292 | 145,411 | 142 K to 145.4 K (+2.42 %) |
| Jun 03 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 19.59 | 19,297 | 378,028 | 19,271 | |
| Jun 03 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 85.02 | 19,297 | 1,640,581 | 141,976 | 161.3 K to 142 K (-11.97 %) |
| Jun 03 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 19.59 | 19,297 | 378,028 | 161,273 | 142 K to 161.3 K (+13.59 %) |
| May 29 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 19.59 | 17,486 | 342,551 | 38,568 | |
| May 29 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 80.03 | 17,486 | 1,399,434 | 141,976 | 159.5 K to 142 K (-10.97 %) |
| May 29 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 19.59 | 17,486 | 342,551 | 159,462 | 142 K to 159.5 K (+12.32 %) |
| May 23 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 19.59 | 1,300 | 25,467 | 56,054 | |
| May 23 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 80.03 | 1,300 | 104,037 | 141,976 | 143.3 K to 142 K (-0.91 %) |
| May 23 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 19.59 | 1,300 | 25,467 | 143,276 | 142 K to 143.3 K (+0.92 %) |
| May 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 19.59 | 731 | 14,320 | 57,354 | |
| May 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 8.65 | 34,376 | 297,352 | 0 | |
| May 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 5.76 | 9,121 | 52,537 | 0 | |
| May 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 35.99 | 22,439 | 807,580 | 9,094 | |
| May 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 80.13 | 731 | 58,574 | 141,976 | 142.7 K to 142 K (-0.51 %) |
| May 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 19.59 | 731 | 14,320 | 142,707 | 142 K to 142.7 K (+0.51 %) |
| May 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 80.13 | 34,376 | 2,754,480 | 141,976 | 176.4 K to 142 K (-19.49 %) |
| May 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 8.65 | 34,376 | 297,352 | 176,352 | 142 K to 176.4 K (+24.21 %) |
| May 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 80.13 | 9,121 | 730,847 | 141,976 | 151.1 K to 142 K (-6.04 %) |
| May 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 5.76 | 9,121 | 52,537 | 151,097 | 142 K to 151.1 K (+6.42 %) |
| May 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 80.13 | 22,439 | 1,797,992 | 141,976 | 164.4 K to 142 K (-13.65 %) |
| May 20 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 35.99 | 22,439 | 807,580 | 164,415 | 142 K to 164.4 K (+15.80 %) |
| May 15 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 8.66 | 34,547 | 299,177 | 0 | |
| May 15 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 75.51 | 34,547 | 2,608,813 | 141,976 | 176.5 K to 142 K (-19.57 %) |
| May 15 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 8.66 | 34,547 | 299,177 | 176,523 | 142 K to 176.5 K (+24.33 %) |
| Feb 08 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | A | 0.00 | 12,339 | 0 | 12,339 | |
| Feb 08 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | A | 81.05 | 66,673 | 5,403,847 | 66,673 | |
| Feb 08 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 83.54 | 920 | 76,859 | 141,639 | 142.6 K to 141.6 K (-0.65 %) |
| Feb 06 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 88.18 | 885 | 78,037 | 139,909 | 140.8 K to 139.9 K (-0.63 %) |
| Feb 06 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 88.06 | 465 | 40,949 | 138,244 | 138.7 K to 138.2 K (-0.34 %) |
| Feb 06 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 88.10 | 1,375 | 121,139 | 137,372 | 138.7 K to 137.4 K (-0.99 %) |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 8.66 | 15,046 | 130,298 | 54,048 | |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 5.76 | 9,122 | 52,543 | 9,121 | |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 35.99 | 5,231 | 188,264 | 31,533 | |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 35.99 | 9,420 | 339,026 | 36,764 | |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 110.26 | 15,046 | 1,659,014 | 135,997 | 151 K to 136 K (-9.96 %) |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 8.66 | 15,046 | 130,298 | 151,043 | 136 K to 151 K (+11.06 %) |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 110.03 | 9,122 | 1,003,708 | 135,997 | 145.1 K to 136 K (-6.29 %) |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 5.76 | 9,122 | 52,543 | 145,119 | 136 K to 145.1 K (+6.71 %) |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 110.00 | 5,231 | 575,410 | 135,997 | 141.2 K to 136 K (-3.70 %) |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 35.99 | 5,231 | 188,264 | 141,228 | 136 K to 141.2 K (+3.85 %) |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 110.10 | 9,420 | 1,037,167 | 135,997 | 145.4 K to 136 K (-6.48 %) |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 35.99 | 9,420 | 339,026 | 145,417 | 136 K to 145.4 K (+6.93 %) |
| Mar 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 43.24 | 14,399 | 622,613 | 59,460 | |
| Mar 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 5.76 | 61,474 | 354,090 | 18,243 | |
| Mar 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 90.00 | 14,399 | 1,295,910 | 135,997 | 150.4 K to 136 K (-9.57 %) |
| Mar 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 43.24 | 14,399 | 622,613 | 150,396 | 136 K to 150.4 K (+10.59 %) |
| Mar 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 90.00 | 61,474 | 5,532,660 | 135,997 | 197.5 K to 136 K (-31.13 %) |
| Mar 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 5.76 | 61,474 | 354,090 | 197,471 | 136 K to 197.5 K (+45.20 %) |
| Feb 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | A | 0.00 | 12,250 | 0 | 12,250 | |
| Feb 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | A | 0.00 | 5,350 | 0 | 5,350 | |
| Feb 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | A | 81.49 | 30,400 | 2,477,296 | 30,400 | |
| Feb 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Payment of Exercise | F | 82.48 | 917 | 75,634 | 135,997 | 136.9 K to 136 K (-0.67 %) |
| Feb 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 83.23 | 887 | 73,821 | 134,264 | 135.2 K to 134.3 K (-0.66 %) |
| Feb 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 83.02 | 1,375 | 114,155 | 132,601 | 134 K to 132.6 K (-1.03 %) |
| Jan 18 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 79.12 | 1,625 | 128,575 | 131,226 | 132.9 K to 131.2 K (-1.22 %) |
| Sep 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 19.59 | 313 | 6,132 | 5,665 | |
| Sep 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 19.59 | 10,937 | 214,256 | 58,085 | |
| Sep 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 8.65 | 2,207 | 19,091 | 8,830 | |
| Sep 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 8.65 | 12,793 | 110,659 | 51,170 | |
| Sep 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 60.00 | 11,250 | 675,000 | 129,601 | 140.9 K to 129.6 K (-7.99 %) |
| Sep 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 19.59 | 11,250 | 220,388 | 140,851 | 129.6 K to 140.9 K (+8.68 %) |
| Sep 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 60.00 | 15,000 | 900,000 | 129,601 | 144.6 K to 129.6 K (-10.37 %) |
| Sep 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 8.65 | 15,000 | 129,750 | 144,601 | 129.6 K to 144.6 K (+11.57 %) |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 8.66 | 2,726 | 23,607 | 80,000 | |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 8.66 | 17,274 | 149,593 | 82,726 | |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 8.66 | 2,726 | 23,607 | 80,000 | |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 5.76 | 5,071 | 29,209 | 100,000 | |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 8.66 | 17,274 | 149,593 | 82,726 | |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 5.76 | 19,929 | 114,791 | 105,071 | |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 5.76 | 5,071 | 29,209 | 100,000 | |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 50.00 | 20,000 | 1,000,000 | 129,601 | 149.6 K to 129.6 K (-13.37 %) |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 5.76 | 19,929 | 114,791 | 105,071 | |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 8.66 | 20,000 | 173,200 | 149,601 | 129.6 K to 149.6 K (+15.43 %) |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 50.00 | 20,000 | 1,000,000 | 129,601 | 149.6 K to 129.6 K (-13.37 %) |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 50.00 | 2,500 | 125,000 | 129,601 | 132.1 K to 129.6 K (-1.89 %) |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 8.66 | 20,000 | 173,200 | 149,601 | 129.6 K to 149.6 K (+15.43 %) |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 5.76 | 25,000 | 144,000 | 154,601 | 129.6 K to 154.6 K (+19.29 %) |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 50.00 | 2,500 | 125,000 | 129,601 | 132.1 K to 129.6 K (-1.89 %) |
| Aug 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 5.76 | 25,000 | 144,000 | 154,601 | 129.6 K to 154.6 K (+19.29 %) |
| Apr 13 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 51.23 | 204 | 10,451 | 129,601 | 129.8 K to 129.6 K (-0.16 %) |
| Apr 13 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 50.41 | 12,861 | 648,323 | 129,805 | 142.7 K to 129.8 K (-9.01 %) |
| Feb 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | A | 0.00 | 10,600 | 0 | 10,600 | |
| Feb 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | A | 43.24 | 76,800 | 3,320,832 | 76,800 | |
| Feb 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 43.14 | 963 | 41,544 | 117,666 | 118.6 K to 117.7 K (-0.81 %) |
| Feb 06 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 42.57 | 1,375 | 58,534 | 116,079 | 117.5 K to 116.1 K (-1.17 %) |
| Jan 18 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 40.63 | 1,625 | 66,024 | 114,704 | 116.3 K to 114.7 K (-1.40 %) |
| Jan 12 2017 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 43.37 | 1,625 | 70,476 | 113,079 | 114.7 K to 113.1 K (-1.42 %) |
| Feb 09 2016 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | A | 0.00 | 20,500 | 0 | 20,500 | |
| Feb 09 2016 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | A | 35.99 | 48,500 | 1,745,515 | 48,500 | |
| Feb 09 2016 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | A | 0.00 | 10,200 | 0 | 10,200 | |
| Feb 04 2016 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 38.13 | 1,375 | 52,429 | 111,454 | 112.8 K to 111.5 K (-1.22 %) |
| Jan 21 2016 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 46.77 | 1,625 | 76,001 | 110,079 | 111.7 K to 110.1 K (-1.45 %) |
| Jan 13 2016 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 44.25 | 1,625 | 71,906 | 108,454 | 110.1 K to 108.5 K (-1.48 %) |
| Oct 19 2015 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 47.78 | 25,000 | 1,194,500 | 106,829 | 131.8 K to 106.8 K (-18.96 %) |
| Feb 29 2008 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Sr Vice President, ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
| Feb 29 2008 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Sr Vice President, ... | Option Exercise | A | 5.12 | 30,000 | 153,600 | 30,000 |